Answers are grounded in this paper and cite their sources.
Background: While pharmaceutical interventions (PIs) serve as safety barriers in Pediatric Intensive Care Units (PICU), their effectiveness relies on acceptance by the multidisciplinary team. Objective: Therefore, this study sought to identify factors associated with the acceptance and refusal of PIs in a PICU, with focus on identifying risk factors for non-acceptance PIs and their association with mortality. Methods: A retrospective analytical study was conducted in a PICU. Zero-Inflated Negative Binomial (ZINB) and standard Negative Binomial (NB) regression models were applied to determine independent predictors of total PIs, accepted PIs (PIa), and Non-Accepted PIs ('PIna)-stratified into Justified (PInaJ) and Unjustified (PInaUJ) refusals. Conclusion: Pharmacotherapeutic risk reflects process complexity and surgical status, not severity. The PInaUJ-mortality link signals team dysfunction during deterioration, supporting risk-based screening and mandatory refusal justification in prescribing systems.
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: